Join the Non-Small Cell Lung Cancer group to help and get support from people like you.
Non-Small Cell Lung Cancer News (Page 9)
Related terms: Cancer, Lung, Non-Small Cell, Lung Cancer, Non-Small Cell, NSCLC
FDA Expands Approved use of Opdivo (nivolumab) to Treat Lung Cancer
March 4, 2015 – The U.S. Food and Drug Administration today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC)...
FDA Expands Approved use of Cyramza to Treat Aggressive Non-Small Cell Lung Cancer
The U.S. Food and Drug Administration today expanded the approved use of Cyramza (ramucirumab) to treat patients with metastatic non-small cell lung cancer (NSCLC). The most common type of lung...
FDA Approves Zykadia (ceritinib) for Metastatic Non-Small Cell Lung Cancer
April 29, 2014 – The U.S. Food and Drug Administration today granted accelerated approval to Zykadia (ceritinib) for patients with a certain type of late-stage (metastatic) non-small cell lung...
FDA Approves Gilotrif for Late Stage Non-Small Cell Lung Cancer
July 12, 2013 – The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific...
FDA Approves Abraxane for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer
SUMMIT, N.J.--(BUSINESS WIRE)--Oct 12, 2012 - Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved Abraxane (paclitaxel protein-bound particles for injectable...
FDA Approves Xalkori with Companion Diagnostic for a Type of Late-Stage Lung Cancer
August 26, 2011 - The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers...
FDA Approves Tarceva as a Maintenance Therapy for Advanced Non-Small Cell Lung Cancer
MELVILLE, N.Y., Apr 16, 2010 (BUSINESS WIRE) – OSI Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the daily pill Tarceva (erlotinib) as a maintenance...